Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantation

Published:2015-01-29 Issue: Volume: Page:
ISSN:
Container-title:Cochrane Database of Systematic Reviews
language:
Short-container-title:

Author:

Peinemann Frank,van Dalen Elvira C,Kahangire Doreen A,Berthold Frank

Publisher

John Wiley & Sons, Ltd

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010685.pub2/epdf/full

Reference134 articles.

1. Impact of radiotherapy for high-risk neuroblastoma: a Children's Cancer Group study;Haas-Kogan;International Journal of Radiation Oncology Biology Physics,2003

2. Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: A Children's Cancer Group study;Maris;Journal of Clinical Oncology,2000

3. Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study;Matthay;Journal of Clinical Oncology,2009

4. Matthay KK Reynolds CP Seeger RC Shimada H Adkins ES Haas-Kogan D Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study. Erratum http://jco.ascopubs.org/content/32/17/1862.full.pdf 1862 3

5. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group;Matthay;New England Journal of Medicine,1999

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of systemic administration of the retinoid Isotretinoin on bone tissue: A narrative literature review;AIMS Bioengineering;2024

2. Alpha-1 Adrenergic Antagonists Sensitize Neuroblastoma to Therapeutic Differentiation;Cancer Research;2023-06-08

3. Targeting ARHGEF12 promotes neuroblastoma differentiation, MYCN degradation, and reduces tumorigenicity;Cellular Oncology;2022-12-15

4. A Multifunctional Conjugated Polymer Developed as an Efficient System for Differentiation of SH-SY5Y Tumour Cells;Polymers;2022-10-14

5. The efficacy and safety of Iodine-131-metaiodobenzylguanidine therapy in patients with neuroblastoma: a meta-analysis;BMC Cancer;2022-02-28